Mark Perry (London, United Kingdom), Fabrizio Luppi (Spilamberto, Italy), Ken Bracke (Ghent, Belgium)
Prevalence of serious post-training inhaler technique errors made by device-naïve patients using three different dry powder inhalers (DPIs) David Price (Aberdeen, United Kingdom), Henry Chrystyn, Sinthia Bosnic-Anticevich, Nicolas Roche, Mathieu Molimard, John Haughney, Federico Lavorini, Dawn Shan, Erika Sims, Anne Burden, Valerie L. Ashton, John Efthimiou, Marek Ferkl, David B. Price
| |
Predictors of good inhaler technique in asthma and COPD Kyra Camilleri (Attard, Malta), Kyra Camilleri, Martin Balzan, Michael Pace Bardon, Emma Schembri, Michael Sullivan, Simon Mifsud, Darlene Muscat, Rachelle Asciaq, Stephen Montefort
| |
A 2 year programme to improve inhaler technique for adult patients with asthma and chronic obstructive pulmonary disease in a Welsh university health board John Amit Benjamin (Pontyclun, United Kingdom), John Amit Benjamin, Rhian Williams, Kathleen Bruce, Owain Jones, Lorna Philips
| |
Is simulation based training in inhaler technique of health care professionals more effective than written information?: A randomised controlled study Xavier Valan Selvaraj Fernando (Llanelli, United Kingdom), Xavier Valan S. Fernando, Anoop Prakash, Anetha Sabanathan, Graham Fent, Victoria Thorley Dickinson, Frank Edenborough, Jack Kastelik, Alan Rigby, Makani Purva, Jaymin Morjaria
| |
Relationship between the ability to learn dry-powder inhaler use and the cognitive functions in patients with COPD Firket Kanat (Konya, Turkey), Baykal Tulek, Nart Bedin Atalay, Ercan Kurtipek, Gulfem Yildirim, Fikret Kanat, Mecit Suerdem
| |
A new clinically relevant method of calculating adherence Imran Sulaiman (Dublin, Ireland), Imran Sulaiman, Jansen Seheult, Isabelle Killane, Elaine MacHale, Richard Reilly, Richard Costello
| |
Optimal adherence with inhaled corticosteroids is related to better health status Kirsten Koehorst-ter Huurne (Enschede, Netherlands), Kirsten Koehorst-ter Huurne, Sharina Kort, Kris Movig, Paul VanderValk, Job Van der Palen, Marjolein Brusse-Keizer
| |
How many adolescents are actually included in randomised trials primarily in adults with asthma? An analysis of recent trial reports Kaylea Clark (Liverpool, United Kingdom), Kaylea Clark, Olivia Annal, Paul Mcnamara, Ian Sinha
| |
Identification of molecular pathways in distinct asthma phenotypes identified in ADEPT Carl Manthey (Radnor, United States of America), Carl Manthey, Vy Hoang, Michael Macoritto, Matthew Loza, Fréedéric Baribaud, Joel Tocker
| |
A new investigational use only automated immunoassay for periostin Nicolette Jeanblanc (North Chicago, United States of America), Nicolette Jeanblanc, Scott Manetz, Rozanne (Yen-Wah) Lee, Meina Liang, Partha Choudhury, Reena Varkey, Ethan Grant, Melissa Parker, Katie Streicher, Lydia Greenlees, Maria Datwyler, Gerard Davis, Koustubh Ranade
| |
GOLD and phenotypes: The new Czech COPD guidelines Vladimír Koblížek (Hradec Kralove, Czech Republic), Vladimir Koblizek, Jan Chlumsky, Vladimir Zindr, Jana Kocianova, Jaromir Zatloukal, Katerina Neumannova, Jakub Zatloukal, Vratislav Sedlak, Jaroslav Zak, Karel Hejduk, Barbora Novotna
| |
Implementation of COPD phenotypes in real life Vladimír Koblížek (Hradec Kralove, Czech Republic), Vladimir Koblizek, Jan Zigmond, Ladislav Pecen, Jan Chlumsky, Barbora Novotna, Viktor Kasak, Jaromir Zatloukal, Martin Blazek, Ales Tichopad
| |
Impact of the GOLD 2011 guidelines on treatment regimens in COPD patients Andrzej Bargiel (Ostrow Wielkopolski, Poland), Andrzej Bargiel, Andrzej Obojski
| |
Eligibility of patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapy David Michael George Halpin (Exeter Devon, United Kingdom), David Halpin, David B. Price, Marjan Kerkhof
| |
The effects of bronchodilators in patients with tuberculosis-destroyed lung and chronic airflow obstruction Jung Seop Eom (Busan, Republic of Korea), Jung Seop Eom, Hye Yun Park, Min Ki Lee, Min Ji Kim
| |
Comparison between anticholinergic and beta-2 agonist treatments by using pletismography and impulse oscillometry Francesco Bini (Pavia, Italy), Francesco Bini, Giorgio De Bernardi, Noemi Grassi, Adriano Vaghi
| |
Biopharmaceutical and chemical compatibility of the combination of salbutamol hemisuccinate and methatropium iodide Tatiana Molostova (Moscow, Russian Federation), Tatiana Molostova, Alexander Chuchalin, Sofia Skachilova, Elena Shilova, Yuriy Kalinin, Tamerlan Balaev, Irina Badygina, Alexander Solovyev
| |
Speech and language therapy for chronic cough and vocal cord dysfunction: Patient satisfaction with therapy given face-to-face and via videocalls Jemma Haines (Wilmslow, United Kingdom), Jemma Haines, Aashish Vyas, Claire Slinger, Siobhan Lillie, Stephen J. Fowler
| |
A randomized, open-label, multicenter study of liposomal amikacin for inhalation in adult patients with nontuberculous mycobacteria (NTM) lung infections caused by mycobacterium avium complex (MAC) David E. Griffith (Tyler, United States of America), David Griffith, Patrick Flume, Kevin Winthrop, Rachel Thomson, Dirk Wagner, Jakko Van Ingen, Liza Micioni, John P. McGinnis II, Carlos Fernandez, Gina Eagle
| |
The characteristics of the minimum inhibitory concentration of antibiotics on pulmonary infections in patients with cystic fibrosis Ludmila Balanetchi (Chisinau, Republic of Moldova), Svetlana Sciuca, Ludmila Balanetchi
| |